How come modafinil is not mainstream among competitive college students and neuroscientists?
Or any other nootropic...
Posted 25 August 2006 - 04:12 AM
Posted 25 August 2006 - 05:16 AM
Posted 26 August 2006 - 02:38 AM
Posted 26 August 2006 - 11:02 AM
Posted 21 September 2006 - 06:48 AM
Anyone know of a healthy published neurologist who actually uses modafinil on a daily basis for cognitive enhancement?
Edited by nootropikamil, 21 September 2006 - 07:34 AM.
Posted 21 September 2006 - 06:16 PM
Posted 21 September 2006 - 07:34 PM
Posted 21 September 2006 - 08:11 PM
Posted 22 September 2006 - 02:35 PM
Posted 23 September 2006 - 12:48 AM
Posted 23 September 2006 - 03:23 AM
Posted 23 September 2006 - 04:57 PM
Posted 23 September 2006 - 07:58 PM
One needs to consider the fraction of people using Provigil for cognitive enhancement vs. the fraction of people who use Provigil for its originally marketed use - narcolepsy.
If the topic of anti-depressants comes up at a party, then it's probably not that fun :-)
Definition of Off-label use
Off-label use: In the United States, the regulations of the Food and Drug Administration (FDA) permit physicians to prescribe approved medications for other than their intended indications. This practice is known as off-label use.
Posted 24 September 2006 - 03:52 PM
Posted 24 September 2006 - 04:28 PM
The reason Provigil isn't more mainstream is its price. That's it. And Xanadu, I had no idea that you were so angry at the poor. Don't lump the libertarian desire to be able to make choices about drugs with a social darwinist disdain for the disadvantaged. It's disingenuous and misinformed. It's also a component of Naziism. Lash out at social conservatism and Big Pharmaceutical, which are really the forces against our ability to choose our substances and to learn the right things about them.
Posted 24 September 2006 - 06:32 PM
The reason Provigil isn't more mainstream is its price.
Posted 27 September 2006 - 08:37 AM
Posted 30 September 2006 - 09:31 PM
Nootropics: Not enough evidence for most people who have been trained to look for self-deception everyehere.
2) Who says it's not mainstream. I ran from the field screaming during my second year. But quite a few people I know who stuck with it are fairly big fans. And amphetamines have long been a dirty little secret in quite a few scientific fields. It shouldn't be that surprising that people aren't so quick to give up their edge, or to admit to walking the line of their countries law.
The effects on me now are only a few steps away from feeling like a miracle in a bottle.
Edited by nootropikamil, 25 March 2007 - 03:50 AM.
Posted 01 October 2006 - 06:58 AM
Actually, Ghostrider...Provigil is marketed as a "smart drug," an anti depressant...and more...
Posted 01 October 2006 - 07:19 AM
Posted 01 October 2006 - 09:38 AM
Posted 01 October 2006 - 07:54 PM
stimulants are smart drugs. This was discovered millennia ago
Posted 02 October 2006 - 05:44 AM
Does Cephalon market Provigil as a "smart drug"? For healthy people or people with ADD? If it is only being actively marketed as a "smart drug" by the parent company towards people with ADD, then it can be considered a "smart drug" in the same way that ADD medications can be considered smart drugs -- truly useful to only a minority subset of the human population and useful as a placebo *at best* for the remainder. Can you show me where the parent company, Cephalon, is claiming that their product is a "smart drug"?
http://www.springerlink.com/content/ab8dmqb55x0ca7vm/[/url]
Cognitive enhancing effects of modafinil in healthy volunteers
Journal Psychopharmacology
Publisher Springer Berlin / Heidelberg
ISSN 0033-3158 (Print) 1432-2072 (Online)
Subject Biomedical and Life Sciences and Medicine
Issue Volume 165, Number 3 / January, 2003
Category Original Investigation
DOI 10.1007/s00213-002-1250-8
Pages 260-269
Online Date Thursday, February 19, 2004
Authors
Danielle C. Turner, Trevor W. Robbins, Luke Clark, Adam R. Aron, Jonathan Dowson, Barbara J. Sahakian
Abstract
Rationale. Modafinil, a novel wake-promoting agent, has been shown to have a similar clinical profile to that of conventional stimulants such as methylphenidate. We were therefore interested in assessing whether modafinil, with its unique pharmacological mode of action, might offer similar potential as a cognitive enhancer, without the side effects commonly experienced with amphetamine-like drugs.
Objectives. The main aim of this study was to evaluate the cognitive enhancing potential of this novel agent using a comprehensive battery of neuropsychological tests.
Methods. Sixty healthy young adult male volunteers received either a single oral dose of placebo, or 100 mg or 200 mg modafinil prior to performing a variety of tasks designed to test memory and attention. A randomised double-blind, between-subjects design was used.
Results. Modafinil significantly enhanced performance on tests of digit span, visual pattern recognition memory, spatial planning and stop-signal reaction time. These performance improvements were complemented by a slowing in latency on three tests: delayed matching to sample, a decision-making task and the spatial planning task. Subjects reported feeling more alert, attentive and energetic on drug. The effects were not clearly dose dependent, except for those seen with the stop-signal paradigm. In contrast to previous findings with methylphenidate, there were no significant effects of drug on spatial memory span, spatial working memory, rapid visual information processing or attentional set-shifting. Additionally, no effects on paired associates learning were identified.
Conclusions. These data indicate that modafinil selectively improves neuropsychological task performance. This improvement may be attributable to an enhanced ability to inhibit pre-potent responses. This effect appears to reduce impulsive responding, suggesting that modafinil may be of benefit in the treatment of attention deficit hyperactivity disorder.
Health Highlights: Sept. 19, 2006
09.19.06, 12:00 AM ET
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
ADHD Cases Linked to Smoke Exposure, Lead
Childhood exposure to lead and smoking during pregnancy may be responsible for one-third of the attention deficit hyperactivity disorder cases in the United States, researchers reported Monday.
The study, headed by researchers at Cincinnati Children's Hospital Medical Center, was the first to estimate the number of ADHD cases attributable to environmental toxins. The study was published online Tuesday in the journal Environmental Health Perspectives, according to an Associated Press report.
The findings build on previous research linking toxic chemicals and other environmental factors to attention problems and developmental and neurological disorders in about 3 percent of all U.S. children.
The researchers analyzed data on almost 4,000 U.S. children ages 4 to 15 who were part of a 1999-2002 government health survey. Included were 135 children treated for ADHD. Children whose mothers smoked during pregnancy were 2.5 times more likely to have ADHD than children who weren't prenatally exposed to tobacco, and children with blood lead levels of more than 2 micrograms per deciliter were four times more likely to have ADHD than children with levels below 0.8 microgram per deciliter.
The government's "acceptable" blood lead level is 10 micrograms per deciliter, and an estimated 310,000 U.S. children ages 1 to 5 have levels exceeding that, the AP reported.
Posted 02 October 2006 - 11:32 AM
Posted 03 October 2006 - 06:26 AM
So, my question remains: why is there resistance to Nootropikamil's labelling modafinil a "smart drug"? Are the studies cited by him inferior in design or execution to the studies cited by advocates of the racetams, idebenone, or hydergine?
Actually, Ghostrider...Provigil is marketed as a "smart drug," an anti depressant...and more...
Posted 03 October 2006 - 06:47 AM
Posted 03 October 2006 - 10:16 AM
It continually amazes me that people equate stimulation with cognitive enhancement. Using stimulants will produce more activity including more alertness and so on. It may increase productivity in some situations. It will not make you smarter. There are many side effects to long term use of any stimulant from caffiene to methamphetamine.
Posted 03 October 2006 - 10:44 AM
It continually amazes me that people equate stimulation with cognitive enhancement. Using stimulants will produce more activity including more alertness and so on. It may increase productivity in some situations. It will not make you smarter. There are many side effects to long term use of any stimulant from caffiene to methamphetamine.
Posted 03 October 2006 - 01:27 PM
Posted 04 October 2006 - 04:01 AM
"systemicanomaly" makes excellent points both about "alertness" as a form of CE and the potential for adverse consequences from modafinil over the long-term. Regarding the latter, it is probably fair to say that we don't have a great deal of information about the long-term effects (in healthy humans) of many proposed nootropic compounds, apart from, say, hydergine and piracetam. So, a measure of caution is warranted, I think. Sometimes less is more.
I believe that Provigil is mainly used by people who want to stay awake, but this supposition does not disprove the idea that Provigil also enhances alertness, task performance, memory, etc. Ghostrider is correct that it is up to the advocates of Provigil to show that it has beneficial effects, but I think the evidence that Nootropikamil presented is at least as substantial as the evidence for any other nootropic.
I'm not aware that doctors prescribe "smart drugs" per se. If you go to an internist and demand desmopressin as part of your study plan for the MCAT, I think you will encounter resistance. The same would apply to other prescription nootropics.
0 members, 1 guests, 0 anonymous users